News and Trends 30 Jun 2022
Funding doubled for company working on breakthrough auto-immune disease therapeutics
…aimed at addressing a range of chronic auto-immune diseases, which affect millions of people worldwide, and particularly type I interferon-mediated diseases such as systemic lupus erythematosus (SLE), dermatomyositis, Sjögren syndrome,…